IFNB1 and myeloid sarcoma: In this respect, it should be noted that despite the therapeutic impact of IFN-β in reducing clinical relapses and MRI activity and the recognized role of calpains in the pathogenesis of MS, the information on the potential of IFN-β in modulating calpains are limited.